alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
STATEMENTS OF INCOME AND CONSOLIDATED BALANCE SHEETS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH 1996 10K.
</LEGEND>
<RESTATED> 
<MULTIPLIER> 1,000,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                              19
<SECURITIES>                                         0
<RECEIVABLES>                                    1,325
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                         55
<CURRENT-ASSETS>                                 1,859
<PP&E>                                           3,945
<DEPRECIATION>                                       0<F1>
<TOTAL-ASSETS>                                   6,346
<CURRENT-LIABILITIES>                            1,834
<BONDS>                                          1,005
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                       2,115
<TOTAL-LIABILITY-AND-EQUITY>                     6,346
<SALES>                                              0
<TOTAL-REVENUES>                                 4,738
<CGS>                                                0<F1>
<TOTAL-COSTS>                                    4,543
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  41
<INCOME-PRETAX>                                    235
<INCOME-TAX>                                        74
<INCOME-CONTINUING>                                160
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  (108)
<CHANGES>                                            0
<NET-INCOME>                                        52
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
<FN>
<F1>NOT SEPARATELY IDENTIFIED IN THE CONSOLIDATED FINANCIAL STATEMENTS OR
ACCOMPANYING NOTES THERETO.
</FN>
        

</TABLE>
EXHIBIT 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350.

In connection with the Annual Report of GSV, Inc. (the "Company") on Form 10-KSB
for the period ending December 31, 2004 (the "Report"), I, Gilad Gat, Chief
Executive Officer, Chief Financial Officer and President of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of
the Securities Exchange Act of 1934; and

2) The information contained in the Report fairly presents, in all material
respects, the Company's financial position and results of operations.

Date: March 31, 2005


                                                /s/ Gilad Gat
                                                -------------------------------
                                                    Gilad Gat
                                                    Chief Executive Officer and
                                                    Chief Financial Officer
Order entered December 13 , 2018

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05 - 18 - 01112 - CV DUAL COMMERCIAL, LLC D/B/A PGI COMMERCIA L LLC, Appellant V. CINCINNATI CASUALTY COMPAN Y, Appellee On Appeal from the County Court at Law No. 5

Dallas County, Texas Trial Court Cause No. CC - 17 - 05795 - E



### O RDER Before the Court is appellant’s December 12, 2018 agreed second motion for an extension of time to file a brief. We GRANT the motion and extend the time to January 16, 2019 . We caution appellant that further request s for extension in this accelerated appeal will be disfavored.

/s/ ADA BROWN JUSTICE
Exhibit 32



CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Report of Strateco Resources Inc. (the “Company”) on Form 10-K for the period ending December 31, 2008 (the “Report”), We, Guy Hébert, President and Chief Executive Officer and Pauline Comtois, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:



(1)

The Report fully complies with the requirements of section 13(a) of 15(d) of the Securities Exchange Act of 1934;



(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



March 13, 2009





/s/ Guy Hébert

__________________

Guy Hébert

President and Chief Executive Officer



March 13, 2009





/s/ Pauline Comtois, CGA

__________________

Pauline Comtois, CGA

Chief Financial Officer
##### 



EXHIBIT 32.1 CERTIFICATION In connection with the Annual Report of Midwest Banc Holdings, Inc. (the Company) on Form
10-K for the fiscal year ending December 31, 2004, as filed with the Securities and Exchange
Commission on March 9, 2005 (the Report), the
undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:  (1)
    The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended; and(2)
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company. /s/ James J. GiancolaName:
    
    James J. GiancolaTitle:
    
    President and
Chief Executive OfficerDate:
    
    May 20, 2005/s/ Daniel R. KadolphName:
    
    Daniel R. KadolphTitle:
    
    Senior Vice President andChief Financial OfficerDate:
    
    May 20, 2005
#### McSWAIN v. STATE.

No. 23753.

Court of Criminal Appeals of Texas.

May 28, 1947.

No appearance for appellant.

Ernest S. Goens, State’s Atty., of - Austin, for the State.

DAVIDSON, Judge.

Appellant was convicted on a charge of misdemeanor theft and his punishment assessed at six months in jail.

The record is before us without a statement of facts or bills of exception. Nothing is presented to this court for review.

The judgment of the trial court is affirmed.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the Judges of the Court of Criminal Appeals and approved by the court.
#### MEDRANO v. STATE.

No. 23774.

Court of Criminal Appeals of Texas.

Nov. 5, 1947.

No appearance for appellant.

Ernest S. Goens, State’s Atty., of Austin, for the State.

HAWKINS, Presiding Judge.

Conviction is for sodomy, punishment confinement in the penitentiary for not less than two nor more than five years.

Under all' the formalities required appellant waived a jury and entered a plea of guilty before the court. The evidence introduced upon the plea supports the judgment. It is not necessary to set out the revolting facts.

The judgment is affirmed.
ktra-ex1027_7.htm



Exhibit 10.27

AMENDMENT TO THE 

KINTARA THERAPEUTICS, INC. 

2017 OMNIBUS EQUITY INCENTIVE PLAN 

Dated: April 26, 2021 

WHEREAS, the Board of Directors of Kintara Therapeutics, Inc. (the “Company”) heretofore established the Kintara Therapeutics, Inc. 2017 Omnibus Equity Incentive Plan (the “Plan”); 

WHEREAS, the Board of Directors desires to amend the Plan to increase the maximum number of shares of common stock of the Company available for grants of Awards thereunder from 6,700,000 to 13,000,000 (not counting shares of common stock that have previously been issued pursuant to the Plan or that are the subject of outstanding Awards under the Plan), all of which are to be available as grants as Incentive Stock Options; and 

WHEREAS, Section 17.2 of the Plan authorizes the Board of Directors to amend the Plan, subject to stockholder approval to the extent that such approval is required by applicable law. 

NOW, THEREFORE, subject to approval of the Company’s stockholders, effective as of the date hereof, the Plan is hereby amended as follows: 

Section 4.1(a) of the Plan is hereby amended in its entirety, to read as follows: 

“(a) Subject to adjustment pursuant to Section 4.3 and any other applicable provisions hereof, the maximum aggregate number of shares of Common Stock which may be issued under all Awards granted to Participants under the Plan shall be 13,000,000 shares; provided, however, that such number shall be reduced by the number of shares of Common Stock issued under the Legacy Plan and/or subject to outstanding grants of options under the Legacy Plan (that is, which have not been forfeited or that have expired without having been exercised). All 13,000,000 of such shares initially available pursuant to this Section 4.1(a) may, but need not, be issued in respect of Incentive Stock Options.” 

 

[Signature Page Follows] 



IN WITNESS WHEREOF, the undersigned has executed this Amendment as evidence of its adoption by the Board of Directors of the Company on the date set forth above. 

 


	
KINTARA THERAPEUTICS, INC.

	
 

	
 

	
By:
	
 
	
/s/ Saiid Zarrabian

	
Name:
	
 
	
Saiid Zarrabian

	
Title:
	
 
	
President and Chief Executive Officer

	
Date:
	
 
	
April 26, 2021
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2819 Engrossed in House (EH)]

113th CONGRESS
  2d Session
                                H. R. 2819

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
at 275 Front Street in Marietta, Ohio, as the ``Veterans Memorial Post 
                           Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. VETERANS MEMORIAL POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 275 Front Street in Marietta, Ohio, shall be known and 
designated as the ``Veterans Memorial Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Veterans 
Memorial Post Office Building''.

            Passed the House of Representatives September 8, 2014.

            Attest:

                                                                 Clerk.
113th CONGRESS

  2d Session

                               H. R. 2819

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
at 275 Front Street in Marietta, Ohio, as the ``Veterans Memorial Post 
                           Office Building''.
```
[Federal Register Volume 65, Number 199 (Friday, October 13, 2000)]
[Notices]
[Pages 60976-60977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-26372]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importation of Controlled Substances; Notice of Application

    Pursuant to Section 1008 of the Controlled Substances Import and 
Export Act (21 U.S.C. 958(I)), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
regulation under Section 1002(a) authorizing the importation of such a 
substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance and opportunity for a hearing.
    Therefore, in accordance with Section 1301.34 of Title 21, Code of 
Federal Regulations (CFR), notice is hereby given that on August 11, 
2000, B.I. Chemical, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 
23805, made application by renewal to the Drug Enforcement 
Administration to be registered as an importer of phenylacetone (8501), 
a basic class of controlled substance listed in Schedule II.
    The firm plans to import the phenylacetone for the bulk manufacture 
of amphetamine.
    Any manufacturer holding, or applying for, registration as a bulk

[[Page 60977]]

manufacturer of this basic class of controlled substance may file 
written comments on or objections to the application described above 
and may, at the same time, file a written request for a hearing on such 
application in accordance with 21 CFR 1301.43 in such form as 
prescribed by 21 CFR 1316.47.
    Any such comments, objections or requests for a hearing may be 
addressed, in quintuplicate, to the Deputy Assistant Administrator, 
Office of Diversion Control, Drug Enforcement Administration, United 
States Department of Justice, Washington, DC 20537, Attention: DEA 
Federal Register representative (CCR), and must be filed no later than 
November 13, 2000.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e), and (f). As noted in a previous notice at 40 FR 43745-46 
(September 23, 1975), all applicants for registration to import a basic 
class of any controlled substance in Schedule I or II are and will 
continue to be required to demonstrate to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration that the requirements for such registration pursuant to 
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(a), (b), (c), 
(d), (e), and (f) are satisfied.

    Dated: September 26, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-26372 Filed 10-12-00; 8:45 am]
BILLING CODE 4410-09-M
EXHIBIT
      32.1





CERTIFICATION
      PURSUANT
      TO




18
      U.S.C.
      SECTION 1350,




AS
      ADOPTED PURSUANT
      TO




SECTION
      906 OF THE SARBANES-OXLEY ACT OF
      2002




In
      connection with theQuarterlyReport
      of The Steak n Shake Company (the "Company") on Form 10-Qfor
      the period ended
      December 17,
      2008as
      filed with the Securities and Exchange Commission on the date hereof (the
      "Report"), each of the undersigned certify, pursuant to 18 U.S.C.
      Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act
      of 2002, that:




(1)
      The Report fully complies with the requirements of section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and




(2)
      The information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.






/s/Sardar
      Biglari


Sardar
      Biglari,
      Executive Chairman and Chief Executive Officer


January
      26, 2009




/s/
      Duane E. Geiger


Duane
      E. Geiger,Interim Chief
      Financial Officer, Vice President and Controller


January
      26, 2009
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5644 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 5644

              To suspend temporarily the duty on Zoxamide.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 8, 2012

  Mr. Gosar introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
              To suspend temporarily the duty on Zoxamide.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ZOXAMIDE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00        3,5-Dichloro-N-(1-  Free            No change      No change      On or before     ''.
                          chloro-3-methyl-                                                  12/31/2015
                          2-oxopentan-3-yl)-
                          4-methylbenzamide
                          (Zoxamide) (CAS
                          No. 156052-68-5)
                          (provided for in
                          subheading
                          2924.29.47)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Case 5:20-cv-00750 Document 1 Filed 06/25/20 Page 1 of 5
Case 5:20-cv-00750 Document 1 Filed 06/25/20 Page 2 of 5
Case 5:20-cv-00750 Document 1 Filed 06/25/20 Page 3 of 5
Case 5:20-cv-00750 Document 1 Filed 06/25/20 Page 4 of 5
Case 5:20-cv-00750 Document 1 Filed 06/25/20 Page 5 of 5
#### Ex parte GRAVES.

No. 23089.

Court of Criminal Appeals of Texas.

March 21, 1945.

*249M. Neal Smith, of Longview, for appellant.

Mike Anglin, Asst. Dist. Atty., of Long-view, and Ernest S. Goens, State’s Atty., of Austin, for the State.

BEAUCHAMP, Justice.

The appellant was charged by complaint with the offense of forgery and the passing of forged instruments in Baton Rouge, Louisiana. The record indicates a large number of forgeries charged against her for the passing of forged instruments on November 11, 1944. Upon application for her extradition the Governor of Texas ordered the relator delivered to the custody of an agent of the State of Louisiana for the purpose of transferring her to that State. The proceedings before the Governor were not contested. She was then arrested in Gregg County and applied for a writ of habeas corpus seeking her release. Upon a hearing before the District Judge she was remanded to the custody of the officer, in accordance with the Governor’s orders.

There were other grounds urged in the hearing before the District Judge than that which we herein discuss. It is unnecessary to consider them in view of our conclusion on the one question.

The first contention made is that there was no regular and sufficient demand made by the Governor of the State of Louisiana to the Governor of Texas for a return of relator to the State of Louisiana. This contention will be sustained. The instrument relied upon as a demand upon the Governor of Texas is identical with that copied and discussed in Ex parte Bergman, 60 Tex.Cr.R. 8, 130 S.W. 174, except that in the instant case the instrument is not addressed to the Governor of Texas or to any other person. We think that the discussion found in Ex parte Anderson, 135 Tex.Cr.R. 291, 120 S.W.2d 259, and Ex parte Gillespie, 136 Tex.Cr.R. 203, 124 S. W.2d 151, both of which construe the Bergman case, will adequately express our views on the question. It would not aid the jurisprudence of the State to reiterate the same things heretofore written in these three cases. In reaching a conclusion in the case the distinction is made only upon the ground that the present record affirmatively shows that there were no other papers presented to the Governor of Texas which might be construed to be a proper demand by the Governor of the State of Louisiana. In the Bergman and Gillespie cases affirmance was based upon the ground that a presumption- rested that there were other papers than those introduced into the record. We think it the burden of relator to show that the instrument attacked was the only one relied upon by the Governor of Texas as a demand from the Governor of the demanding state. It appears from the record under consideration that this burden was met.

It is, therefore, ordered that the judgment of the trial court be and the same is reversed and the appellant is ordered discharged.
EXHIBIT 32.1

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of J.Crew Group, Inc. (the Company) on Form 10-K for the period ended February 2, 2008 as
filed with the Securities and Exchange Commission on the date hereof (the Report), we, Millard S. Drexler, Chief Executive Officer of the Company, and James S. Scully, Executive Vice President and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of each of our knowledge:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: March 26, 2008



|                                                                    
|--------------------------------------------------------------------
|/s/    MILLARD S.
DREXLER                                           
|Millard S. Drexler Chief Executive Officer                          
|                                                                    
|/s/    JAMES S. SCULLY                                              
|James S. Scully Executive Vice President and Chief Financial Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 10.77
 
 Docket No. 10-055-PCA-SMIn the Matter ofPrompt Corrective ActionMIDWEST BANK AND TRUST COMPANY
    
    
    Directive Issued Upon ConsentElmwood Park, Illinois
    
    
    Pursuant to Section 38 of theFederal Deposit Insurance Act, asAmended
 o




---



##### 



o
  2




---



##### 



o
  o
  3




---



##### 



o
  (a)
    
    Mr. Charles F. Luse
Assistant Vice President
Federal Reserve Bank of Chicago
230 South LaSalle Street
Chicago, Illinois 60604(b)
    
    Mr. Roberto R. Herencia
President and Chief Executive Officer
Midwest Bank and Trust Company
501 W. North Avenue
Melrose Park, Illinois 60160
     4




---



##### 



MIDWEST BANK AND TRUST COMPANY
    
    
    
    BOARD OF GOVERNORS OF THE
FEDERAL RESERVE SYSTEMBy:
    
    /s/ Roberto R. Herencia
    
    
    
    By:
    
    /s/ Robert de V. FriersonRoberto R. Herencia
    
    
    
    
    
    Robert de V. FriersonPresident and CEO
    
    
    
    
    
    Deputy Secretary of the Board
 5